Prediction of reverse remodeling at cardiac MR imaging soon after first stsegment-elevation myocardial infarction: Results of a large prospective registry

Radiology

Volumn 278, Issue 1, 2016, Pages 54-63

  Bodi, Vicente ^a   Monmeneu, Jose V ^b   Perez, Jose T Ortiz ^c   Lereu, Maria P Lopez ^b   Bonanad, Clara ^c   Husser, Oliver ^e   Minana, Gemma ^a   Gomez, Cristina ^a   Nunez, Julio ^a   Forteza, Maria J ^a   Hervas, Arantxa ^a   De Dios, Elena ^a   Moratal, David ^d   Bosch, Xavier ^d   Chorro, Francisco J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Hospital General Universitario Avda   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; NUCLEAR PROTEIN; RSF1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ADULT; AGED; CARDIAC GATED IMAGING; FEMALE; HEART INFARCTION; HEART VENTRICLE REMODELING; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; REGISTER; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC-GATED IMAGING TECHNIQUES; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; TRANS-ACTIVATORS; VENTRICULAR REMODELING;

EID: 84952880854     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015142674     Document Type: Article

References (21)

1. Mann DL, Barger PM, Burkhoff D. Myocardial recovery and the failing heart: myth, magic, or molecular target? J Am Coll Cardiol 2012;60(24):2465-2472.
2. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348(20):2007-2018.
3. Koitabashi N, Kass DA. Reverse remodeling in heart failure-mechanisms and therapeutic opportunities. Nat Rev Cardiol 2012; 9(3):147-157.
4. Fraccarollo D, Galuppo P, Bauersachs J. Novel therapeutic approaches to post-infarction remodelling. Cardiovasc Res 2012; 94(2):293-303.
5. Hellawell JL, Margulies KB. Myocardial reverse remodeling. Cardiovasc Ther 2012; 30(3):172-181.
6. Linde C, Gold MR, Abraham WT, et al. Long-Term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reverses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Eur Heart J 2013;34(33):2592-2599.
7. Breithardt OA. Reversing heart failure by CRT: how long do the effects last? Eur Heart J 2013;34(33):2582-2584.
8. Ambardekar AV, Buttrick PM. Reverse remodeling with left ventricular assist devices: A review of clinical, cellular, and molecular effects. Circ Heart Fail 2011;4(2):224-233.
9. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: The role of myofibroblasts. Nat Rev Cardiol 2010; 7(1):30-37.
10. Eitel I, de Waha S, Wöhrle J, et al. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol 2014;64(12):1217-1226.
11. van Kranenburg M, Magro M, Thiele H, et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging 2014;7(9):930-939.
12. Bodi V, Sanchis J, Lopez-Lereu MP, et al. Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol 2005;46(9):1747-1752.
13. Bodi V, Husser O, Sanchis J, et al. Contractile reserve and extent of transmural necrosis in the setting of myocardial stunning: comparison at cardiac MR imaging. Radiology 2010;255(3):755-763.
14. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33(20):2551-2567.
15. Taylor J. 2012 ESC Guidelines on acute myocardial infarction (STEMI). Eur Heart J 2012;33(20):2501-2502.
16. Spanish Society of Cardiology Working Group on the Clinical Practice Guidelines for ST-Elevation Acute Coronary Syndrome; Group of Expert Reviewers for the Clinical Practice Guidelines for ST-Elevation Acute Coronary Syndrome; Spanish Society of Cardiology Clinical Practice Guidelines Committee, et al. Comments on the ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation. Rev Esp Cardiol (Engl Ed) 2013;66(1):5-11.
17. Funaro S, La Torre G, Madonna M, et al. Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarc-Tion Contrast Imaging (AMICI) multicenter study. Eur Heart J 2009;30(5):566-575.
18. Carrabba N, Parodi G, Valenti R, Migliorini A, Bellandi B, Antoniucci D. Prognostic value of reverse left ventricular remodeling after primary angioplasty for STEMI. Atherosclerosis 2012;222(1):123-128.
19. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33(14):1787-1847. [Published correction appears in Eur Heart J 2013;34(2):158.]
20. Volpi A, Cavalli A, Turato R, Barlera S, Santoro E, Negri E. Incidence and short-Term prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nellInfarto Miocardico (GISSI-3) Data Base. Am Heart J 2001;142(1):87-92.
21. El Aidi H, Adams A, Moons KG, et al. Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: A systematic review of prognostic studies. J Am Coll Cardiol 2014;63(11):1031-1045.